R1 RCM price target raised to $15 from $10 at KeyBanc

KeyBanc analyst Scott Schoenhaus raised the firm’s price target on R1 RCM to $15 from $10 to reflect a higher valuation multiple of 14.5-times on his 2023 adjusted EBITDA estimate. The analyst keeps an Overweight rating on the shares.